NIH-funded research R01 grant

Bacteria-responsive hydrogel that releases antibiotics and probiotics for chronic wound infections

Official title: Bacteria-Triggered Hydrogel Delivery of Antibiotics and Probiotics for the Treatment of Chronic Wound Infections

Funded at Brown University · NIH-11365476 · Data updated 2026-11-12

A bacteria-triggered hydrogel dressing delivers antibiotics and helpful probiotics directly to chronic wounds, aiming to fight resistant bacteria and promote healing.

More Wound research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBrown University
NIH-funded
Lab location1 site (Providence, United States)
Project startJuly 6, 2026
Project endJune 30, 2031
Funding year2026
Award (this year)$542,599
NIH project number1R01AI193021-01A1
Project IDNIH-11365476 on NIH RePORTER

Who could benefit from this research

Could help

Adults with chronic wound infections, particularly those involving antibiotic-resistant bacteria, who require localized wound care.

Less likely to help

Patients without chronic wounds or with wounds not caused by antibiotic-resistant bacteria may not benefit from this approach.

What this research studies

This project seeks a smart wound dressing that stays hydrated and oxygen-rich while releasing medicines only when bacteria are present. It combines antibiotics with probiotics like Lactobacilli to disrupt biofilms formed by bugs such as MRSA and Pseudomonas, potentially reducing resistance development. The dressing uses bacteria-responsive materials that release drugs on demand, targeting infection locally without constant high-dose exposure. The work is designed to translate into a patient-facing wound care option that could improve healing times and reduce complications from resistant infections.

Why it matters

Potential benefit: If successful, patients with chronic wound infections could experience faster healing and fewer complications through targeted, on-demand treatment that minimizes antibiotic overuse.

How similar studies have gone: Previous work with bacteria-responsive hydrogels shows promise, but integrating probiotics and antibiotics for real-time on-demand release is a novel approach.

Where this research is happening

  • Brown University
    Providence, United States
    Active

Researchers

  • Principal investigator: Shukla, Anita — Brown University
  • Study coordinator: Shukla, Anita

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.